Description
ONCOTYPE GENE EXPRESSION BREAST CANCER TESTING SERVICES OY 3
Base award description: ONCOTYPE GENE EXPRESSION BREAST CANCER TESTING SERVICES
Modification chain · 9 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2022-05-12+$51,809= $51,809
- Mod P000012022-11-07+$155,428= $207,238
- Mod P000022023-05-04+$207,238= $414,475
- Mod P000032023-11-02-$158,882= $255,593
- Mod P000042024-05-13+$207,238= $462,831
- Mod P000052024-10-01-$131,250= $331,580
- Mod P000062025-05-14+$207,238= $538,818
- Mod P000072025-10-23-$151,974= $386,844
- Mod P000082026-05-12+$207,238= $594,081
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2022-05-12 | +$51,809 | $51,809 | ONCOTYPE GENE EXPRESSION BREAST CANCER TESTING SERVICES |
| Mod P00001· FUNDING ONLY ACTION | 2022-11-07 | +$155,428 | $207,238 | ONCOTYPE GENE EXPRESSION BREAST CANCER TESTING SERVICES |
| Mod P00002· EXERCISE AN OPTION | 2023-05-04 | +$207,238 | $414,475 | ONCOTYPE GENE EXPRESSION BREAST CANCER TESTING SERVICES |
| Mod P00003· FUNDING ONLY ACTION | 2023-11-02 | −$158,882 | $255,593 | ONCOTYPE GENE EXPRESSION BREAST CANCER TESTING SERVICES |
| Mod P00004· EXERCISE AN OPTION | 2024-05-13 | +$207,238 | $462,831 | ONCOTYPE GENE EXPRESSION BREAST CANCER TESTING SERVICES |
| Mod P00005· FUNDING ONLY ACTION | 2024-10-01 | −$131,250 | $331,580 | ONCOTYPE GENE EXPRESSION BREAST CANCER TESTING SERVICES DE OB OY 1 |
| Mod P00006· EXERCISE AN OPTION | 2025-05-14 | +$207,238 | $538,818 | ONCOTYPE GENE EXPRESSION BREAST CANCER TESTING SERVICES OY 3 |
| Mod P00007· OTHER ADMINISTRATIVE ACTION | 2025-10-23 | −$151,974 | $386,844 | ONCOTYPE GENE EXPRESSION BREAST CANCER TESTING SERVICES OY 3 |
| Mod P00008· EXERCISE AN OPTION | 2026-05-12 | +$207,238 | $594,081 | ONCOTYPE GENE EXPRESSION BREAST CANCER TESTING SERVICES OY 3 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NGBXEJX5GLE9)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25726N0419 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · Q301 · REFERENCE LABORATORY TESTING | $127,174 | FY2026 |
| 36C25726N0252 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · Q301 · REFERENCE LABORATORY TESTING | $52,215 | FY2026 |
| 36C25526N0057 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · Q301 · REFERENCE LABORATORY TESTING | $3,454 | FY2026 |
| 36C25526N0054 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · Q301 · REFERENCE LABORATORY TESTING | $24,259 | FY2026 |
| 36C25526N0056 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · Q301 · REFERENCE LABORATORY TESTING | $3,454 | FY2026 |
| 36C25526N0055 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · Q301 · REFERENCE LABORATORY TESTING | $3,116 | FY2026 |
Other recipients under Q301 from 248-NETWORK CONTRACT OFFICE 8 (36C248) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24826N0684 | VERACYTE, INC. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $49,730 | FY2026 |
| 36C24826P0831 | UNIVERSITY OF MIAMI | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $178,265 | FY2026 |
| 36C24826N0548 | D & D LABORATORY LLC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $14,915 | FY2026 |
| 36C24826P0651 | ROCHE DIAGNOSTICS CORPORATION | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $239,858 | FY2026 |
| 36C24826P0221 | REPROSOURCE FERTILITY DIAGNOSTICS, INC. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $27,500 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24822N0432_3600_V797D70053_3600 · retrieved 2026-09-26.